Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bludigo in patients with renal impairment undergoing ureteral patency assessment
NCT06085183Phase 4Recruiting
- Sponsor
- Provepharma
- Start
- Dec 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indigotindisulfonate sodium, sponsored by Provepharma. Started Dec 2023; status: recruiting.
02
Drugs
indigotindisulfonate sodium
Beyond the preview
Go deeper on NCT06085183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085183.